There has been plenty of talk in recent months about the disparity between North Korea talking the talk and actually walking the walk.
For decades, it was impossible to tell just how effective any of North Korea’s weaponry really was, given the thick shroud of secrecy surrounding the despotic regime. Until the middle of 2017, it was doubtful that Kim Jong Un would ever have a missile precise enough to strike the American west coast, let alone anywhere in the world, yet, here we are, ramping up nuclear drills in a number of U.S. cities in response to his three successful ICBM launches.
Beyond the threat of a thermonuclear strike, Kim Jong Un is certainly maniacal enough to employ some of the more tried and true methods of mass fatalities as well, with what the world only assumed was a possible biological and chemical weapons program tucked away somewhere in the isolated nation.
Now, a medical examination of a recent defector has given us proof positive of that danger’s reality.
“Traces of anthrax antibodies were discovered in the system of a North Korean soldier who had defected to South Korea at some point in 2017, a local South Korean television station reported Tuesday.
“’Anthrax antibodies have been found in the North Korean soldier who defected this year,’ according an unnamed South Korean official speaking to Channel A.
“The news comes amid earlier reports that North Korea was beginning tests to mount anthrax onto intercontinental ballistic missiles capable of reaching the U.S.”
This revelation certainly bolsters the possibility that North Korea is nearing the completion of an anthrax-based weapon to be used in the near future.
Given the momentous tension that has become standard between the hermit kingdom and the United States, action by the latter is nearly imminent. Now, given the possibility of the regime’s biological response, U.S. military leaders may have to head back to the drawing board before stepping foot across the DMZ.